Alethea Capital Management »

Atrium Therapeutics shares owned by Alethea Capital Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Alethea Capital Management from 13F filings

Historical chart of Alethea Capital Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Alethea Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Alethea Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $585k 44k 13.37